{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:15:41Z","timestamp":1785417341065,"version":"3.56.0"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dongguk University College of Medicine Research Fund"},{"id":[{"id":"https:\/\/ror.org\/057q6n778","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Chromobox protein homolog 2 (CBX2), a member of the polycomb group of proteins that plays a role in chromatin remodeling, has been associated with multiple types of cancer. However, its characterization in liver hepatocellular carcinoma (LIHC) has not been fully elucidated. This study aims to systemically evaluate the expression, prognostic value, epigenetic regulation, and ncRNAs of CBX2 in LIHC. Materials and Methods: We performed a comprehensive in silico analysis to assess CBX2 expression at mRNA and protein levels, correlate its expression with clinical characteristics and prognosis, and explore DNA methylation and ncRNA-mediated regulatory networks. Multiple public databases (TIMER2.0, UALCAN, Human Protein Atlas, KM Plotter, MethSurv, miRNet, and ENCORI) were utilized to conduct expression, survival analysis, and construct a network encompassing miRNAs, lncRNAs, and pseudogenes. Results: CBX2 expression was found to be elevated in LIHC at both the mRNA and protein expression level. Increased CBX2 expression was closely linked with unfavorable clinical outcome. Methylation analysis indicated that various CpG sites, exhibiting both hypermethylation and hypomethylation patterns, were correlated with CBX2 expression and patient prognosis. Among the identified ncRNAs, hsa-miR-101-3p tended to be downregulated, whereas hsa-miR-222-3p was significantly upregulated in LIHC, and both were associated with CBX2 expression and clinical outcomes. The constructed ncRNA interaction network suggested potential associations among miRNA, lncRNAs, and pseudogenes that may be linked to tumor progression. Conclusions: Our results suggest that CBX2 was overexpressed in LIHC and may be associated with epigenetic alterations and ncRNA-related regulatory interactions. Its expression shows a relationship with clinical prognosis, suggesting that CBX2 could serve as a candidate biomarker. The proposed CBX2-associated ncRNA network represents a potential framework for further investigation, although additional experimental validation is required to confirm its biological and clinical relevance. Consequently, our findings suggest that CBX2 may serve as a potential prognostic biomarker and therapeutic target in LIHC, potentially influenced by specific epigenetic and post-transcriptional mechanisms.<\/jats:p>","DOI":"10.3390\/medicina62050842","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:32:22Z","timestamp":1777469542000},"page":"842","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic and ncRNA Regulation of CBX2 in Liver Hepatocellular Carcinoma: A Comprehensive Multi-Omics Analysis for Understanding Biological Significance"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5656-468X","authenticated-orcid":false,"given":"Kyu-Shik","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Pharmacology, College of Medicine, Dongguk University, Gyeongju 38066, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Heon","family":"Kim","sequence":"additional","affiliation":[{"name":"Brain Science & Engineering Institute, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6183-3100","authenticated-orcid":false,"given":"Jongwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine, Dongguk University, Gyeongju 38066, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"3711","article-title":"Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: The role of HBsAg","volume":"11","author":"Lee","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes. Dev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41416-025-02969-8","article-title":"The epigenetic basis of hepatocellular carcinoma\u2014Mechanisms and potential directions for biomarkers and therapeutics","volume":"132","author":"Lin","year":"2025","journal-title":"Br. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1609575","DOI":"10.1155\/2017\/1609575","article-title":"New Insights into the Epigenetics of Hepatocellular Carcinoma","volume":"2017","author":"Wahid","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-023-06682-5","article-title":"Epigenetic regulation during cancer transitions across 11 tumour types","volume":"623","author":"Terekhanova","year":"2023","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"eaal2380","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.trecan.2018.04.007","article-title":"Epigenetic Priming in Cancer Initiation","volume":"4","author":"Hauer","year":"2018","journal-title":"Trends Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3748\/wjg.14.1741","article-title":"DNA methylation in hepatocellular carcinoma","volume":"14","author":"Tischoff","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nmat4997","article-title":"Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Nat. Mater."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.ctrv.2024.102763","article-title":"Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications","volume":"128","author":"Zhu","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","article-title":"Small and long non-coding RNAs: Past, present, and future","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1756-9966-32-96","article-title":"Regulation of microRNAs by epigenetics and their interplay involved in cancer","volume":"32","author":"Liu","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_15","first-page":"2554","article-title":"MiR-98 inhibits malignant progression via targeting MTDH in squamous cell carcinoma of the head and neck","volume":"7","author":"Tan","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.2015.170","article-title":"miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells","volume":"113","author":"Higashi","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/tri.12733","article-title":"A possible role of microRNAs as predictive markers for the recurrence of hepatocellular carcinoma after liver transplantation","volume":"29","author":"Liese","year":"2016","journal-title":"Transpl. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: Definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s13277-013-0658-6","article-title":"Long noncoding RNA: An emerging paradigm of cancer research","volume":"34","author":"Qiu","year":"2013","journal-title":"Tumour Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2020.10.042","article-title":"Functional long non-coding RNAs in hepatocellular carcinoma","volume":"500","author":"Xie","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer: A long non-coding RNA point of view","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Guo, X., Lin, M., Rockowitz, S., Lachman, H.M., and Zheng, D. (2014). Characterization of human pseudogene-derived non-coding RNAs for functional potential. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093972"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lou, W., Ding, B., and Fu, P. (2020). Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00085"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nature09144","article-title":"A coding-independent function of gene and pseudogene mRNAs regulates tumour biology","volume":"465","author":"Poliseno","year":"2010","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"re5","DOI":"10.1126\/scisignal.2002858","article-title":"Pseudogenes: Newly discovered players in human cancer","volume":"5","author":"Poliseno","year":"2012","journal-title":"Sci. Signal"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1038\/ncomms4963","article-title":"The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes","volume":"5","author":"Han","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.18632\/oncotarget.3290","article-title":"Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma","volume":"6","author":"Peng","year":"2015","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jeong, E.A., Lee, M.H., Bae, A.N., Kim, J., Park, J.H., and Lee, J.H. (2024). A Comprehensive Analysis of HOXB13 Expression in Hepatocellular Carcinoma. Medicina, 60.","DOI":"10.3390\/medicina60050716"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bae, A.N., Kim, J., Park, J.H., Lee, J.H., and Choi, E. (2023). Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata. Medicina, 59.","DOI":"10.3390\/medicina59101782"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.24171\/j.phrp.2023.0229","article-title":"The value of CDC42 effector protein 2 as a novel prognostic biomarker in liver hepatocellular carcinoma: A comprehensive data analysis","volume":"14","author":"Kim","year":"2023","journal-title":"Osong Public Health Res. Perspect."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13072-015-0014-8","article-title":"Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer","volume":"8","author":"Mallona","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/pro.3987","article-title":"The Human Protein Atlas-Spatial localization of the human proteome in health and disease","volume":"30","author":"Digre","year":"2021","journal-title":"Protein Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.7150\/jca.44475","article-title":"The Prognostic Value of the Chromobox Family in Human Ovarian Cancer","volume":"11","author":"Xu","year":"2020","journal-title":"J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","article-title":"OncoDB: An interactive online database for analysis of gene expression and viral infection in cancer","volume":"50","author":"Tang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5114\/pjp.2021.114174","article-title":"Elevated expression of IGFL1 indicates unfavorable prognosis in lung adenocarcinoma through promotion of cell proliferation and inhibition of apoptosis","volume":"72","author":"Wang","year":"2021","journal-title":"Pol. J. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1002\/cam4.2969","article-title":"Identification of hub methylated-CpG sites and associated genes in oral squamous cell carcinoma","volume":"9","author":"Dai","year":"2020","journal-title":"Cancer Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.21037\/tcr-24-314","article-title":"Combining non-invasive liquid biopsy and a methylation analysis to assess surgical risk for early esophageal cancer","volume":"13","author":"Chen","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12938-021-00952-x","article-title":"Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis","volume":"20","author":"Li","year":"2021","journal-title":"Biomed. Eng. Online"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"118435","DOI":"10.1016\/j.lfs.2020.118435","article-title":"Identifying of miR-98-5p\/IGF1 axis contributes breast cancer progression using comprehensive bioinformatic analyses methods and experiments validation","volume":"261","author":"Sun","year":"2020","journal-title":"Life Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc1279","article-title":"The history of cancer epigenetics","volume":"4","author":"Feinberg","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.omto.2021.03.009","article-title":"lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p\/HOXA9 axis","volume":"21","author":"Wang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/carcin\/bgaa093","article-title":"LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p\/FOXM1 signaling axis","volume":"42","author":"Zhang","year":"2021","journal-title":"Carcinogenesis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(89)92228-9","article-title":"Halothane anaesthetic and the ozone layer","volume":"1","author":"Norreslet","year":"1989","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/epi.23062","article-title":"Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips","volume":"8","author":"Shen","year":"2013","journal-title":"Epigenetics"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/842\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:22:23Z","timestamp":1777472543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050842"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050842","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}